PSORIASIS VULGARIS
Clinical trials for PSORIASIS VULGARIS explained in plain language.
Never miss a new study
Get alerted when new PSORIASIS VULGARIS trials appear
Sign up with your email to follow new studies for PSORIASIS VULGARIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heavier psoriasis patients may need a stronger dose of brodalumab
Disease control CompletedThis study tested whether a higher dose of the drug brodalumab works better than the standard dose for people with moderate-to-severe plaque psoriasis who weigh at least 120 kg. The trial involved 385 adults and lasted 52 weeks. The main goal was to see if more patients on the hi…
Matched conditions: PSORIASIS VULGARIS
Phase: PHASE4 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Psoriasis breakthrough: lower drug doses may work just as well
Disease control CompletedThis study tested whether psoriasis patients who are stable on biologic drugs (IL17 or IL23 inhibitors) can safely reduce their dose without their skin condition getting worse. Researchers enrolled 244 adults with plaque psoriasis who had been on a normal dose for at least 6 mont…
Matched conditions: PSORIASIS VULGARIS
Phase: PHASE4 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Light-Activated gel shows promise for psoriasis in early trial
Disease control CompletedThis study tested a gel called SGX302, which is activated by visible light, on 15 people with mild-to-moderate plaque psoriasis. The goal was to see if it could clear or nearly clear skin lesions over 18 weeks. The treatment is applied to the skin and then exposed to light, aimin…
Matched conditions: PSORIASIS VULGARIS
Phase: PHASE2 • Sponsor: Soligenix • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could a plant cream soothe psoriasis? new trial tests it
Symptom relief CompletedThis study tested a cream made from plant compounds (total coumarins) in 88 adults with mild-to-moderate psoriasis. Participants applied the cream or a placebo for several weeks. The goal was to see if the cream safely reduces skin redness, scaling, and thickness better than a pl…
Matched conditions: PSORIASIS VULGARIS
Phase: PHASE2 • Sponsor: Psoriasis Research Institute of Guangzhou • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC